- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06588777
Ultrasound Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed Hassan, Master
- Phone Number: 01158195158
- Email: ahmedhassan199466@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ainshams University Hospitals
-
Contact:
- Ainshams
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aging ≥ 21 years to ≤ 70 of both sexes.
- Patients undergoing Laparoscopic cholecystectomy surgeries.
- ASA physical status classes I - II.
Exclusion Criteria:
- Patient's refusal of procedure or participation in the study.
- ASA classes III or above.
- Coagulopathy and bleeding disorders.
- Evidence of Local skin infections at site of injection.
- Body mass index >40kg/m2
- A history of relevant local anesthetic allergy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)
Using the in plane technique A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline.
A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage.
It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage and 20 mL of 0.25% bupivacaine will be injected into the lower surface of the chondrium to make Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA).
|
transversus abdominis, internal oblique, and external oblique muscles will be identified with a high-frequency (10 MHz) linear probe on the costochondral angle in the sagittal plane under ultrasound guidance at the 10th costal margin.
A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline.
A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage.
It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage
Other Names:
|
|
Experimental: Quadratus lumborum block
Using the in plane technique the probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis. The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle. |
using ultrasound guidance (Sonosite turbo M, Bothell, Washington, USA) and a curved ultrasound probe (2.5-7.5 MHz). The probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis. The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to first Rescue Analgesia
Time Frame: 24 hours postoperative
|
Is to measure the first time to resque analgesia postoperative (24 hours)
|
24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The total requirements of rescue analgesia Meperidine (pethidine) over the first 24 hours postoperative
Time Frame: 24 hours postoperative
|
24 hours postoperative
|
|
Heart rate
Time Frame: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
|
Blood pressure
Time Frame: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
|
Spo2 measuring
Time Frame: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MD92/2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.